The FDA has approved revisions to the safety labeling for triamcinolone acetonide nasal spray, atazanavir sulfate capsules, and rocuronium bromide intravenous injection.
Medscape Medical News
A multiethnic study on 4 continents found that glucocerebrosidase gene mutations are the most common genetic risk factor for Parkinson's disease.
Medscape Medical News
Adoptive cellular gene immunotherapy is a developing technology that may offer new hope to patients with cancer. The current case study and discussion describe the application of this treatment to a patient with glioblastoma mulitforme.
Nature Clinical Practice Oncology
Preliminary findings suggest that subthalamic nucleus stimulation may be effective in treating severe, refractory obsessive-compulsive disorder. However, the procedure is also associated with an increased risk for serious adverse events.
Medscape Medical News
A new imaging study looking at plaque burden in the brains of individuals with and without dementia strongly supports the long-held cognitive-reserve hypothesis, that those with more education are better able to withstand Alzheimer's disease pathology.
Medscape Medical News
A randomized trial of MK-677, a growth hormone secretagogue, shows no benefit for patients with Alzheimer's disease, despite successfully increasing serum insulinlike growth factor-1, the treatment target in this trial.
Medscape Medical News
Urban carotid endarterectomy (CEA) patients currently bear a higher risk factor burden and face worse outcomes than those reported in earlier clinical trials, according to a findings published in the November issue of Stroke.
Reuters Health Information
Author(s): Fei Guo, Bo Hong, Xiaorong Gao and Shangkai Gao
Affiliation(s): Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, 100084, People's Republic of China
Author(s): Sung-Phil Kim, John D Simeral, Leigh R Hochberg, John P Donoghue and Michael J Black
Affiliation(s): Department of Computer Science, Brown University, Box 1910, 115 Waterman St, Providence, RI 02912, USA; The Center for Restorative and Regenerative Medicine, Rehabilitation R&D Service, Department of Veterans Affairs, Providence, RI 02912, USA; Department of Neuroscience, Brown University, Providence, RI 02912, USA; Department of Neurology, Massachusetts General, Brigham and Women's and Spaulding Rehab. Hospitals, Harvard Medical School, Boston, MA 02114, USA; Cyberkinetics Neurotechnology Systems, Inc., Foxborough, MA 02035, USA